Abstract 4536: GFS784, a next-generation ADC with a novel panRAS(ON) inhibitor payload
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Genfleet Therapeutics (Shanghai) Inc. (China)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148962025
